Zheng Y. Almstead

Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma.

Y. Liu, Nita Patel, David B Rawlins, 2015, ACS medicinal chemistry letters.

Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma.

Alan G. E. Wilson, Y. Liu, D. Rice, 2009, Journal of medicinal chemistry.

Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

Alan G. E. Wilson, N. C. Goodwin, F. Mseeh, 2009, Journal of medicinal chemistry.